Investigation of Biomarkers in Susac Syndrome
NCT01273792 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2021-07-29
Summary
Susac Syndrome is a rare disease and the establishment of the diagnosis is often difficult. The aim of this investigation is to identify relevant biomarkers and to elucidate the pathogenesis of Susac syndrome
Conditions
- Susac Syndrome
Sponsors & Collaborators
-
Charite University, Berlin, Germany
lead OTHER
Principal Investigators
-
Jan M Dörr, MD · NeuroCure Clinical Research Center, Charité Universitaetsmedizin Berlin
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
NCT02471352 ·Status: RECRUITING
-
A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis
NCT05300932 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Biomarker for Patients With Fabry Disease (BioFabry)
NCT02778295 ·Status: WITHDRAWN
-
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 ·Status: RECRUITING
-
Diagnostic Role of Renal Biopsy in Patients With Fabry Disease
NCT06801288 ·Status: COMPLETED
-
Development and Prevention of Severe Heart Disease in Systemic Sclerosis
NCT01829126 ·Status: UNKNOWN
-
Familial Systemic Scleroderma
NCT07343115 ·Status: RECRUITING
-
Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
NCT07265999 ·Status: RECRUITING
-
Study of in Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis
NCT05312073 ·Status: COMPLETED ·Phase: NA
-
Biomarker for Hurler Disease (BioHurler)
NCT02298712 ·Status: WITHDRAWN
-
Prevalence and Characterization of Pain in RASopathies
NCT06355622 ·Status: RECRUITING ·Phase: NA
-
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594 ·Status: UNKNOWN
-
Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
NCT00418132 ·Status: TERMINATED ·Phase: PHASE1
-
Oral Manifestations of Systemic Sclerosis
NCT02371005 ·Status: TERMINATED ·Phase: NA
-
Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre
NCT04265144 ·Status: RECRUITING ·Phase: NA
-
Prevention and Treatment of Digital Ulcers in Systemic Sclerosis
NCT01836263 ·Status: UNKNOWN
-
Utility of Breath-holding Test in Systemic Sclerosis
NCT04484948 ·Status: COMPLETED ·Phase: NA
-
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485 ·Status: COMPLETED ·Phase: PHASE1
-
Genetic Basis of Rosacea Study (Control)
NCT02749786 ·Status: COMPLETED ·Phase: NA
-
ScATtEred Rare Disease Biobanks: a Model of Sample/Data Collection With susTainablE and Shared Criteria
NCT06782230 ·Status: RECRUITING
-
Skin Cancer in Swiss Transplant Cohort Study
NCT02361229 ·Status: UNKNOWN
-
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465 ·Status: COMPLETED ·Phase: NA
-
Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis
NCT05488327 ·Status: UNKNOWN ·Phase: NA
-
Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients
NCT07282717 ·Status: NOT_YET_RECRUITING